Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype

被引:65
作者
Ohanna, Mickael [1 ]
Cerezo, Mickael [1 ,5 ]
Nottet, Nicolas [2 ]
Bille, Karine [1 ]
Didier, Robin [1 ]
Beranger, Guillaume [1 ]
Mograbi, Baharia [3 ]
Rocchi, Stephane [1 ]
Yvan-Charvet, Laurent [4 ]
Ballotti, Robert [1 ]
Bertolotto, Corine [1 ]
机构
[1] Univ Nice Cote dAzur, Equipe Labellisee Assoc Rech Canc ARC 2015, INSERM, Biol & Pathol Melanocytes,U1065,C3M, F-06204 Nice, France
[2] Univ Nice Cote dAzur, INSERM, C3M, F-06204 Nice, France
[3] Univ Nice Cote dAzur, INSERM, Equipe Labellisee ARC, U1081,IRCAN,UMR7284,CNRS, F-06107 Nice, France
[4] Univ Nice Cote dAzur, TeamATIP Avenir, INSERM, U1065,C3M, F-06204 Nice, France
[5] INSERM, U981, Villejuif, France
关键词
melanoma; metabolism; NAD; targeted therapy; SIGNAL TRANSDUCER; PHASE-I; METABOLISM; MUTANT; TRANSCRIPTION; STAT5; MITF; IDENTIFICATION; PROLIFERATION; REGULATORS;
D O I
10.1101/gad.305854.117
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
In BRAF(V600E) melanoma cells, a global metabolomic analysis discloses a decrease in nicotinamide adenine dinucleotide (NAD(+)) levels upon PLX4032 treatment that is conveyed by a STAT5 inhibition and a transcriptional regulation of the nicotinamide phosphoribosyltransferase (NAMPT) gene. NAMPT inhibition decreases melanoma cell proliferation both in vitro and in vivo, while forced NAMPT expression renders melanoma cells resistant to PLX4032. NAMPT expression induces transcriptomic and epigenetic reshufflings that steer melanoma cells toward an invasive phenotype associated with resistance to targeted therapies and immunotherapies. Therefore, NAMPT, the key enzyme in the NAD(+) salvage pathway, appears as a rational target in targeted therapy-resistant melanoma cells and a key player in phenotypic plasticity of melanoma cells.
引用
收藏
页码:448 / 461
页数:14
相关论文
共 54 条
[1]  
Aparicio O, 2005, CURR PROTOC MOL BIOL, V21, P1
[2]   Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells [J].
Baenke, Franziska ;
Chaneton, Barbara ;
Smith, Matthew ;
Van Den Broek, Niels ;
Hogan, Kate ;
Tang, Haoran ;
Viros, Amaya ;
Martin, Matthew ;
Galbraith, Laura ;
Girotti, Maria R. ;
Dhomen, Nathalie ;
Gottlieb, Eyal ;
Marais, Richard .
MOLECULAR ONCOLOGY, 2016, 10 (01) :73-84
[3]   The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease [J].
Bai, Peter ;
Canto, Carles .
CELL METABOLISM, 2012, 16 (03) :290-295
[4]   Nicotinamide adenine dinucleotide stimulates oligomerization, interaction with adenovirus E1A and an intrinsic dehydrogenase activity of CtBP [J].
Balasubramanian, P ;
Zhao, LJ ;
Chinnadurai, G .
FEBS LETTERS, 2003, 537 (1-3) :157-160
[5]   FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973 [J].
Baudy, Andreas R. ;
Dogan, Taner ;
Flores-Mercado, Judith E. ;
Hoeflich, Klaus P. ;
Su, Fei ;
van Bruggen, Nicholas ;
Williams, Simon-Peter .
EJNMMI RESEARCH, 2012, 2
[6]   Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes [J].
Bertolotto, C ;
Abbe, P ;
Hemesath, TJ ;
Bille, K ;
Fisher, DE ;
Ortonne, JP ;
Ballotti, R .
JOURNAL OF CELL BIOLOGY, 1998, 142 (03) :827-835
[7]   A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma [J].
Bertolotto, Corine ;
Lesueur, Fabienne ;
Giuliano, Sandy ;
Strub, Thomas ;
de Lichy, Mahaut ;
Bille, Karine ;
Dessen, Philippe ;
d'Hayer, Benoit ;
Mohamdi, Hamida ;
Remenieras, Audrey ;
Maubec, Eve ;
de la Fouchardiere, Arnaud ;
Molinie, Vincent ;
Vabres, Pierre ;
Dalle, Stephane ;
Poulalhon, Nicolas ;
Martin-Denavit, Tanguy ;
Thomas, Luc ;
Andry-Benzaquen, Pascale ;
Dupin, Nicolas ;
Boitier, Francoise ;
Rossi, Annick ;
Perrot, Jean-Luc ;
Labeille, Bruno ;
Robert, Caroline ;
Escudier, Bernard ;
Caron, Olivier ;
Brugieres, Laurence ;
Saule, Simon ;
Gardie, Betty ;
Gad, Sophie ;
Richard, Stephane ;
Couturier, Jerome ;
Teh, Bin Tean ;
Ghiorzo, Paola ;
Pastorino, Lorenza ;
Puig, Susana ;
Badenas, Celia ;
Olsson, Hakan ;
Ingvar, Christian ;
Rouleau, Etienne ;
Lidereau, Rosette ;
Bahadoran, Philippe ;
Vielh, Philippe ;
Corda, Eve ;
Blanche, Helene ;
Zelenika, Diana ;
Galan, Pilar ;
Chaudru, Valerie ;
Lenoir, Gilbert M. .
NATURE, 2011, 480 (7375) :94-U259
[8]   Aurora B Is Regulated by the Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase (MAPK/ERK) Signaling Pathway and Is a Valuable Potential Target in Melanoma Cells [J].
Bonet, Caroline ;
Giuliano, Sandy ;
Ohanna, Mickael ;
Bille, Karine ;
Allegra, Maryline ;
Lacour, Jean-Philippe ;
Bahadoran, Philippe ;
Rocchi, Stephane ;
Ballotti, Robert ;
Bertolotto, Corine .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (35) :29887-29898
[9]   NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus [J].
Canto, Carles ;
Menzies, Keir J. ;
Auwerx, Johan .
CELL METABOLISM, 2015, 22 (01) :31-53
[10]   A Switch in the Expression of Embryonic EMT-Inducers Drives the Development of Malignant Melanoma [J].
Caramel, Julie ;
Papadogeorgakis, Eftychios ;
Hill, Louise ;
Browne, Gareth J. ;
Richard, Geoffrey ;
Wierinckx, Anne ;
Saldanha, Gerald ;
Osborne, Joy ;
Hutchinson, Peter ;
Tse, Gina ;
Lachuer, Joel ;
Puisieux, Alain ;
Pringle, J. Howard ;
Ansieau, Stephane ;
Tulchinsky, Eugene .
CANCER CELL, 2013, 24 (04) :466-480